Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes
about
Thymosin beta 4 is dispensable for murine cardiac development and functionEpicardial Epithelial-to-Mesenchymal Transition in Heart Development and DiseaseProgramming and reprogramming a human heart cellEndocardial and epicardial epithelial to mesenchymal transitions in heart development and diseaseDevelopmental origin and lineage plasticity of endogenous cardiac stem cellsMyocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heartChemical genetics and its potential in cardiac stem cell therapy.Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery.The transcription factors Tbx18 and Wt1 control the epicardial epithelial-mesenchymal transition through bi-directional regulation of Slug in murine primary epicardial cells.Strategies for cardiac regeneration and repair.An emerging consensus on cardiac regeneration.Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease.New approaches under development: cardiovascular embryology applied to heart disease.Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Human fetal and adult epicardial-derived cells: a novel model to study their activation.The epicardium as a candidate for heart regeneration.Heart repair: from natural mechanisms of cardiomyocyte production to the design of new cardiac therapies.Thymosin β4 and cardiac regeneration: are we missing a beat?Epicardial progenitor cells in cardiac development and regeneration.Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine.Thymosin β4 and cardiac protection: implication in inflammation and fibrosis.Recent advances in heart regeneration.Cardiac regeneration: current therapies-future concepts.Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis.The epicardium signals the way towards heart regenerationGeneration of cardiac progenitor cells through epicardial to mesenchymal transition.Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart.Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics.Coelomic epithelium-derived cells in visceral morphogenesis.Innate heart regeneration: endogenous cellular sources and exogenous therapeutic amplification.Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue.Epicardium-Derived Heart Repair.Prospects for improving neovascularization of the ischemic heart: Lessons from development.The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away.Cardiac stem cells: translation to human studies.Colonizing the heart from the epicardial side.BRG1-SWI/SNF-dependent regulation of the Wt1 transcriptional landscape mediates epicardial activity during heart development and disease.Smooth muscle origin of postnatal 2nd CVP is pre-determined in early embryo.Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium.Genetic Cre-loxP assessment of epicardial cell fate using Wt1-driven Cre alleles.
P2860
Q24632556-114DD435-0E0E-4C9F-A56C-B7D608F9DE7BQ26767045-232C91D6-457E-4496-91BD-31B1BE778555Q26823933-FC1445B9-2F03-479D-A0D0-94AF604198A0Q26830155-115E6336-21F0-4BCA-982A-5678614C9155Q28080127-1D6DF905-4752-4246-A368-619CB1B573E8Q33853829-FC118E4A-4565-4183-A972-BA080747B67AQ34183137-2CE85CA3-F875-43EC-9115-0280017574ADQ34476907-DE8E9CA9-335F-4384-B0F5-086E1B9C82EBQ34612490-C1712C9F-4FB0-4D6A-A697-B0F89124E5FAQ34795299-27326BD6-96AE-4A83-8BC6-B4E61D035115Q35565809-545AD25D-1925-4DE1-AEFE-C01581A236B8Q35906030-00DB206F-9BFE-4B30-8415-C4C37F4E3565Q36497186-834272CF-CD90-4BD8-991B-F769FBEF8AACQ37016190-3D2B47F0-3C8D-4088-946D-0FA625B2DBC2Q37456851-4F700FDD-5B77-4F1A-9886-B31801010E24Q37687321-DB3C3590-9C89-4E63-907E-0E74A49B6E8BQ38006736-6B579066-C7BF-44CC-A367-77225193B814Q38013063-E2B018F1-5205-401E-8F12-1050698D90EAQ38015278-08C633D6-868C-4ED7-8DA9-CE315CA16AABQ38050451-8D068633-0AFA-4098-A069-71384F21F7B6Q38050454-62FE6C6E-AD4F-42E7-B638-E7F5D6C3D7A6Q38147034-83FBE1A8-039B-44EF-929D-DFF3303D6D36Q38164335-FE5B8FBD-EF29-4715-B8EC-BA8D358B8E0EQ38220004-6D06B890-5836-46E4-9006-E03F3730AB2DQ38220618-53FC4DEE-C525-4504-AF1F-3E61C427A695Q38460765-6918A4BC-D8F1-48E5-A2EE-64A9A3332BABQ38533285-84D612CD-3B7A-4B6F-AC16-238356EE7634Q38654054-F372BF69-0144-4DFA-9620-656EF745068CQ38659781-6BDFADE1-1BC9-4FA3-98DC-FE57AD33A017Q38916204-F5A5C81B-8FC4-49F0-B5BF-C698B9C6CAB8Q38919999-CD37A80E-D099-4362-841F-E83638CE59E6Q38930599-5489FAA7-68EF-428B-9B81-A64A82C6124EQ39012408-FCF64282-4C02-46C0-ADAC-BFAF20979764Q39095681-C7403DBA-34AB-4457-A62A-16E2CD44DC1DQ39310120-DBCD1BD3-AC1C-45A2-9A69-008C5E0C023FQ39623089-7232FFF2-8FF9-4765-B921-EE782F05E625Q41126801-ADDC26EF-745A-47A2-BD51-B01DD5D51EF0Q41384230-0D2A5588-740B-4D0D-B1E7-C4AB2D53BD63Q42001387-C4E1C290-6A76-4922-9072-FF4DBAB6FC5CQ42434214-51387F4A-CC2B-4A70-9813-0949EBA2190A
P2860
Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Thymosin beta 4 treatment afte ...... dial cells into cardiomyocytes
@en
type
label
Thymosin beta 4 treatment afte ...... dial cells into cardiomyocytes
@en
prefLabel
Thymosin beta 4 treatment afte ...... dial cells into cardiomyocytes
@en
P2093
P2860
P1476
Thymosin beta 4 treatment afte ...... dial cells into cardiomyocytes
@en
P2093
Alexander von Gise
Jin-Hee Oh
Juan M Melero-Martin
Kai Hong Wu
Lingjuan He
Pingzhu Zhou
Tianyuan Hu
P2860
P356
10.1016/J.YJMCC.2011.08.020
P577
2011-08-26T00:00:00Z